MetLife Investment Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.7M Buy
331,087
+14,545
+5% +$1.09M 0.15% 112
2025
Q1
$20.1M Buy
316,542
+258,776
+448% +$16.4M 0.11% 155
2024
Q4
$4.51M Buy
57,766
+3,241
+6% +$253K 0.02% 616
2024
Q3
$4.38M Sell
54,525
-279
-0.5% -$22.4K 0.03% 602
2024
Q2
$4.53M Buy
54,804
+2,155
+4% +$178K 0.03% 551
2024
Q1
$4.49M Sell
52,649
-1,808
-3% -$154K 0.03% 550
2023
Q4
$4.66M Sell
54,457
-433
-0.8% -$37K 0.03% 493
2023
Q3
$4.92M Sell
54,890
-1,176
-2% -$105K 0.04% 410
2023
Q2
$4.77M Sell
56,066
-389
-0.7% -$33.1K 0.03% 472
2023
Q1
$4.67M Sell
56,455
-927
-2% -$76.7K 0.03% 488
2022
Q4
$4.51M Sell
57,382
-920
-2% -$72.4K 0.03% 503
2022
Q3
$4.32M Sell
58,302
-261
-0.4% -$19.3K 0.04% 484
2022
Q2
$3.82M Sell
58,563
-1,521
-3% -$99.1K 0.03% 590
2022
Q1
$3.8M Buy
60,084
+17,188
+40% +$1.09M 0.02% 696
2021
Q4
$2.28M Buy
42,896
+283
+0.7% +$15K 0.02% 823
2021
Q3
$3.01M Sell
42,613
-977
-2% -$69K 0.03% 635
2021
Q2
$2.9M Buy
43,590
+17,338
+66% +$1.16M 0.03% 693
2021
Q1
$2.91M Sell
26,252
-1,534
-6% -$170K 0.03% 690
2020
Q4
$3.3M Sell
27,786
-1,241
-4% -$147K 0.03% 573
2020
Q3
$2.53M Sell
29,027
-895
-3% -$78.1K 0.03% 620
2020
Q2
$2.68M Sell
29,922
-20,473
-41% -$1.83M 0.03% 581
2020
Q1
$5.02M Sell
50,395
-775
-2% -$77.2K 0.07% 253
2019
Q4
$5.88M Sell
51,170
-436
-0.8% -$50.1K 0.06% 292
2019
Q3
$6.51M Sell
51,606
-1,541
-3% -$194K 0.07% 252
2019
Q2
$6.4M Sell
53,147
-685
-1% -$82.4K 0.07% 266
2019
Q1
$4.71M Sell
53,832
-422
-0.8% -$36.9K 0.05% 361
2018
Q4
$5.43M Sell
54,254
-132
-0.2% -$13.2K 0.07% 264
2018
Q3
$6.23M Sell
54,386
-3,569
-6% -$409K 0.06% 278
2018
Q2
$5.2M Buy
57,955
+34,009
+142% +$3.05M 0.06% 291
2018
Q1
$1.75M Hold
23,946
0.02% 818
2017
Q4
$1.39M Buy
+23,946
New +$1.39M 0.02% 898